NCT00041080View on ClinicalTrials.gov

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial CancerStage IV Ovarian Epithelial Cancer
Interventions
DRUG

tamoxifen citrate

Given orally

DRUG

thalidomide

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

National Cancer Institute (NCI)

NIH

NCT00041080 - Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter